Evidence map›Paper›PMID 28889214›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2017

SERPING1 mRNA overexpression in monocytes from HIV+ patients.

C Sanfilippo, D Cambria, A Longo, M Palumbo, R Avola, M Pinzone, G Nunnari, F Condorelli, G Musumeci, R Imbesi and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Effect ofBiomedicines · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

C SanfilippoDepartment of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
D CambriaDepartment of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
A LongoDepartment of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
M PalumboDepartment of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
R AvolaDepartment of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
M PinzoneDepartment of Pathology and Laboratory Medicine, School of Medicine, University of Pennsylvania, Philadelphia, USA.
G NunnariUnit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
F CondorelliDepartment of Pharmacological Sciences, Università del Piemonte Orientale "A. Avogadro", 28100, Novara, Italy.
G MusumeciHuman Anatomy and Histology Section, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy.
R ImbesiHuman Anatomy and Histology Section, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy.
P CastogiovanniHuman Anatomy and Histology Section, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy.
L MalaguarneraDepartment of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
Michelino Di RosaDepartment of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy. mdirosa@unict.it.ORCID http://orcid.org/0000-0002-1837-9325
University of Catania · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Messina · ITUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe HIV-1 virus activates the complement system, an essential element of the immune system. SERPING1 is a protease inhibitor that disables C1r/C1s in the C1 complex of the classical complement pathway.

methodsIn this paper, we performed an analysis of several microarrays deposited in GEO dataset to demonstrate that SERPING1 mRNA is modulated in CD14

resultsOur analysis shows that SERPING1 mRNA is overexpressed in monocytes from HIV-1+ patients and the expression levels correlate positively with viral load and negatively with the CD4

conclusionsFrom the outcome of our investigation, it is possible to conclude that SERPING1 and its network serve as important components of the innate immune system to restrict HIV-1 infection.

Indexed as

CD4 Lymphocyte CountCD4-Positive T-LymphocytesComplement C1 Inhibitor ProteinHIV-1HIV InfectionsHumansMonocytesRNA, MessengerViral LoadComplement C1 Inhibitor ProteinRNA, MessengerSERPING1 protein, humanC1-INHComplementHIV-1IFN-gammaMonocyteSERPING1

Identifiers

PMID28889214
OpenAlexW2755076413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.